An expanding list of information resources on the COVID-19 Pandemic. A link to Resources, Information, FAQs and Research on this pandemic will be provided (in red - here), and at the bottom of this post . . .
A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the symptoms of adult long-COVID patients or in preventing the development of the condition in adolescents.